Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Akeso
Pharma
Summit updates ivonescimab survival data ahead of PDUFA
In the latest ivonescimab survival data, “most western patients have now discontinued treatment or completed two years of treatment,” Summit said.
Angus Liu
Jul 22, 2026 10:58am
Behind the headlines of ASCO 2026
Jun 5, 2026 9:38am
At ASCO, China biotech industry cements its coming of age
Jun 3, 2026 8:50am
Akeso's 34% overall survival win comes with caveats
May 31, 2026 8:00am
More biotech hawkishness, Pfizer’s $10B deal—Fierce Pharma Asia
May 29, 2026 8:30am
Previewing Akeso's high-stakes ASCO plenary for PD-1/VEGF
May 27, 2026 11:25am
